TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
ConditionCancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorTempus AI
About this trial
This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.
Eligibility criteria
Qualifiers
≥18 years of age
Willing to participate in the research
Able to provide informed consent
Must be diagnosed with cancer
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
500 Participants
are grouped into 7 trial groups7
Trial groupsSee each trial group below.
Sponsors and collaborators
Source ClinicalTrials.gov